✦ LIBER ✦

Adjuvant tamoxifen in postmenopausal stage II breast cancer five years on

✍ Scribed by Mikl, J.; Czerwenka, K.; Salzer, H.; Spona, J.; Aiginger, P.; Kubista, E.; Sevelda, P.; Staffen, A.; Zielinski, C.C.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

One year of adjuvant tamoxifen compared

✍ Ejlertsen, Bent; Jensen, Maj-Britt; Elversang, Johanna; Rasmussen, Birgitte B.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 541 KB

ADJUVANT CHEMOTHERAPY COMBINED WITH TAMO

✍ Zielinski, C.C.; Kubista, E.; Salzer, H.; Sevelda, P.; Langer, M.; Staffen, A.; 📂 Article 📅 1986 🏛 The Lancet 🌐 English ⚖ 119 KB

Oestrogenic effects of adjuvant tamoxife

✍ Fornander, Tommy; Rutqvist, Lars E.; Wilking, Nils; Carlström, K.; von Schoultz, 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 436 KB

Randomised trial of two versus five year

✍ M. Sacco; M. Valentini; M. Belfiglio; A. Nicolucci; F. Pellegrini 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Adjuvant tamoxifen treatment in postmeno

✍ Arne Wallgren; Edward Baral; Ulla Glas; Leif Karnström; Bo Nordenskiöld; Nils-Ol 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 185 KB

A Benefit of Letrozole in Postmenopausal

✍ Heather DeGrendele; Joyce A. O'Shaughnessy 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 94 KB